Cargando…

Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium

BACKGROUND: Smoking is the most important individual risk factor for many cancer sites but its association with breast and prostate cancer is not entirely clear. Rate advancement periods (RAPs) may enhance communication of smoking related risk to the general population. Thus, we estimated RAPs for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ordóñez-Mena, José Manuel, Schöttker, Ben, Mons, Ute, Jenab, Mazda, Freisling, Heinz, Bueno-de-Mesquita, Bas, O’Doherty, Mark G., Scott, Angela, Kee, Frank, Stricker, Bruno H., Hofman, Albert, de Keyser, Catherine E., Ruiter, Rikje, Söderberg, Stefan, Jousilahti, Pekka, Kuulasmaa, Kari, Freedman, Neal D., Wilsgaard, Tom, de Groot, Lisette CPGM, Kampman, Ellen, Håkansson, Niclas, Orsini, Nicola, Wolk, Alicja, Nilsson, Lena Maria, Tjønneland, Anne, Pająk, Andrzej, Malyutina, Sofia, Kubínová, Růžena, Tamosiunas, Abdonas, Bobak, Martin, Katsoulis, Michail, Orfanos, Philippos, Boffetta, Paolo, Trichopoulou, Antonia, Brenner, Hermann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820956/
https://www.ncbi.nlm.nih.gov/pubmed/27044418
http://dx.doi.org/10.1186/s12916-016-0607-5
_version_ 1782425505506525184
author Ordóñez-Mena, José Manuel
Schöttker, Ben
Mons, Ute
Jenab, Mazda
Freisling, Heinz
Bueno-de-Mesquita, Bas
O’Doherty, Mark G.
Scott, Angela
Kee, Frank
Stricker, Bruno H.
Hofman, Albert
de Keyser, Catherine E.
Ruiter, Rikje
Söderberg, Stefan
Jousilahti, Pekka
Kuulasmaa, Kari
Freedman, Neal D.
Wilsgaard, Tom
de Groot, Lisette CPGM
Kampman, Ellen
Håkansson, Niclas
Orsini, Nicola
Wolk, Alicja
Nilsson, Lena Maria
Tjønneland, Anne
Pająk, Andrzej
Malyutina, Sofia
Kubínová, Růžena
Tamosiunas, Abdonas
Bobak, Martin
Katsoulis, Michail
Orfanos, Philippos
Boffetta, Paolo
Trichopoulou, Antonia
Brenner, Hermann
author_facet Ordóñez-Mena, José Manuel
Schöttker, Ben
Mons, Ute
Jenab, Mazda
Freisling, Heinz
Bueno-de-Mesquita, Bas
O’Doherty, Mark G.
Scott, Angela
Kee, Frank
Stricker, Bruno H.
Hofman, Albert
de Keyser, Catherine E.
Ruiter, Rikje
Söderberg, Stefan
Jousilahti, Pekka
Kuulasmaa, Kari
Freedman, Neal D.
Wilsgaard, Tom
de Groot, Lisette CPGM
Kampman, Ellen
Håkansson, Niclas
Orsini, Nicola
Wolk, Alicja
Nilsson, Lena Maria
Tjønneland, Anne
Pająk, Andrzej
Malyutina, Sofia
Kubínová, Růžena
Tamosiunas, Abdonas
Bobak, Martin
Katsoulis, Michail
Orfanos, Philippos
Boffetta, Paolo
Trichopoulou, Antonia
Brenner, Hermann
author_sort Ordóñez-Mena, José Manuel
collection PubMed
description BACKGROUND: Smoking is the most important individual risk factor for many cancer sites but its association with breast and prostate cancer is not entirely clear. Rate advancement periods (RAPs) may enhance communication of smoking related risk to the general population. Thus, we estimated RAPs for the association of smoking exposure (smoking status, time since smoking cessation, smoking intensity, and duration) with total and site-specific (lung, breast, colorectal, prostate, gastric, head and neck, and pancreatic) cancer incidence and mortality. METHODS: This is a meta-analysis of 19 population-based prospective cohort studies with individual participant data for 897,021 European and American adults. For each cohort we calculated hazard ratios (HRs) for the association of smoking exposure with cancer outcomes using Cox regression adjusted for a common set of the most important potential confounding variables. RAPs (in years) were calculated as the ratio of the logarithms of the HRs for a given smoking exposure variable and age. Meta-analyses were employed to summarize cohort-specific HRs and RAPs. RESULTS: Overall, 140,205 subjects had a first incident cancer, and 53,164 died from cancer, during an average follow-up of 12 years. Current smoking advanced the overall risk of developing and dying from cancer by eight and ten years, respectively, compared with never smokers. The greatest advancements in cancer risk and mortality were seen for lung cancer and the least for breast cancer. Smoking cessation was statistically significantly associated with delays in the risk of cancer development and mortality compared with continued smoking. CONCLUSIONS: This investigation shows that smoking, even among older adults, considerably advances, and cessation delays, the risk of developing and dying from cancer. These findings may be helpful in more effectively communicating the harmful effects of smoking and the beneficial effect of smoking cessation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-016-0607-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4820956
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48209562016-04-06 Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium Ordóñez-Mena, José Manuel Schöttker, Ben Mons, Ute Jenab, Mazda Freisling, Heinz Bueno-de-Mesquita, Bas O’Doherty, Mark G. Scott, Angela Kee, Frank Stricker, Bruno H. Hofman, Albert de Keyser, Catherine E. Ruiter, Rikje Söderberg, Stefan Jousilahti, Pekka Kuulasmaa, Kari Freedman, Neal D. Wilsgaard, Tom de Groot, Lisette CPGM Kampman, Ellen Håkansson, Niclas Orsini, Nicola Wolk, Alicja Nilsson, Lena Maria Tjønneland, Anne Pająk, Andrzej Malyutina, Sofia Kubínová, Růžena Tamosiunas, Abdonas Bobak, Martin Katsoulis, Michail Orfanos, Philippos Boffetta, Paolo Trichopoulou, Antonia Brenner, Hermann BMC Med Research Article BACKGROUND: Smoking is the most important individual risk factor for many cancer sites but its association with breast and prostate cancer is not entirely clear. Rate advancement periods (RAPs) may enhance communication of smoking related risk to the general population. Thus, we estimated RAPs for the association of smoking exposure (smoking status, time since smoking cessation, smoking intensity, and duration) with total and site-specific (lung, breast, colorectal, prostate, gastric, head and neck, and pancreatic) cancer incidence and mortality. METHODS: This is a meta-analysis of 19 population-based prospective cohort studies with individual participant data for 897,021 European and American adults. For each cohort we calculated hazard ratios (HRs) for the association of smoking exposure with cancer outcomes using Cox regression adjusted for a common set of the most important potential confounding variables. RAPs (in years) were calculated as the ratio of the logarithms of the HRs for a given smoking exposure variable and age. Meta-analyses were employed to summarize cohort-specific HRs and RAPs. RESULTS: Overall, 140,205 subjects had a first incident cancer, and 53,164 died from cancer, during an average follow-up of 12 years. Current smoking advanced the overall risk of developing and dying from cancer by eight and ten years, respectively, compared with never smokers. The greatest advancements in cancer risk and mortality were seen for lung cancer and the least for breast cancer. Smoking cessation was statistically significantly associated with delays in the risk of cancer development and mortality compared with continued smoking. CONCLUSIONS: This investigation shows that smoking, even among older adults, considerably advances, and cessation delays, the risk of developing and dying from cancer. These findings may be helpful in more effectively communicating the harmful effects of smoking and the beneficial effect of smoking cessation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-016-0607-5) contains supplementary material, which is available to authorized users. BioMed Central 2016-04-05 /pmc/articles/PMC4820956/ /pubmed/27044418 http://dx.doi.org/10.1186/s12916-016-0607-5 Text en © Ordóñez-Mena et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ordóñez-Mena, José Manuel
Schöttker, Ben
Mons, Ute
Jenab, Mazda
Freisling, Heinz
Bueno-de-Mesquita, Bas
O’Doherty, Mark G.
Scott, Angela
Kee, Frank
Stricker, Bruno H.
Hofman, Albert
de Keyser, Catherine E.
Ruiter, Rikje
Söderberg, Stefan
Jousilahti, Pekka
Kuulasmaa, Kari
Freedman, Neal D.
Wilsgaard, Tom
de Groot, Lisette CPGM
Kampman, Ellen
Håkansson, Niclas
Orsini, Nicola
Wolk, Alicja
Nilsson, Lena Maria
Tjønneland, Anne
Pająk, Andrzej
Malyutina, Sofia
Kubínová, Růžena
Tamosiunas, Abdonas
Bobak, Martin
Katsoulis, Michail
Orfanos, Philippos
Boffetta, Paolo
Trichopoulou, Antonia
Brenner, Hermann
Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium
title Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium
title_full Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium
title_fullStr Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium
title_full_unstemmed Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium
title_short Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium
title_sort quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the chances consortium
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820956/
https://www.ncbi.nlm.nih.gov/pubmed/27044418
http://dx.doi.org/10.1186/s12916-016-0607-5
work_keys_str_mv AT ordonezmenajosemanuel quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT schottkerben quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT monsute quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT jenabmazda quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT freislingheinz quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT buenodemesquitabas quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT odohertymarkg quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT scottangela quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT keefrank quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT strickerbrunoh quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT hofmanalbert quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT dekeysercatherinee quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT ruiterrikje quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT soderbergstefan quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT jousilahtipekka quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT kuulasmaakari quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT freedmanneald quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT wilsgaardtom quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT degrootlisettecpgm quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT kampmanellen quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT hakanssonniclas quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT orsininicola quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT wolkalicja quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT nilssonlenamaria quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT tjønnelandanne quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT pajakandrzej quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT malyutinasofia quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT kubinovaruzena quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT tamosiunasabdonas quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT bobakmartin quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT katsoulismichail quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT orfanosphilippos quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT boffettapaolo quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT trichopoulouantonia quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT brennerhermann quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium
AT quantificationofthesmokingassociatedcancerriskwithrateadvancementperiodsmetaanalysisofindividualparticipantdatafromcohortsofthechancesconsortium